Targeted screening to participants in ≥90th percentile of polygenic risk score results in detection of cancer warranting clinical management in 55.1 percent.

At the 38th Annual Meeting of the Engineering & Urology Society (EUS), Mr. Dan Luca of UCLA presented a compelling advancement in the imaging of prostate cancer (PCa), identifying prostate ductal ...

Objective To compare the diagnostic outcomes of the current approach of transrectal ultrasound (TRUS)-guided biopsy in men with suspected prostate cancer ... MRI-targeted biopsy, the biopsy needle can ...

A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage ...

A global research team has discovered a breakthrough set of urine biomarkers for prostate cancer that outperform the ...

Image Credit: Norgen Biotek Corp. It is ... are a key component in the personalized medicine approach to cancer treatment. The Prostate Specific Antigen (PSA) protein is produced by the prostate ...

The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...

Sir Chris Hoy has spoken about his hope for advances in prostate cancer research. Picture: Max Mumby/Indigo/Getty Images Professor Rakesh Heer, chair of urology at Imperial College London and part ...

A new urine test for prostate cancer has shown promising accuracy, potentially surpassing current PSA blood tests and paving the way for routine screening in men, comparable to breast cancer ...